Our global footprint spans key regions across the world, creating an integrated network that drives innovation and growth.
Italy plays a central role, grounded in a strong heritage and long-standing scientific and industrial expertise, alongside our expanding presence in the United States and across Europe.
Bologna | Headquarters
Our global corporate headquarters house most of Alfasigma's major central functions.
Milan | Offices
Executive office hosting international and corporate functions.
Alanno | Manufacturing Plant
Specialising in both Captive and CMO activities.
Pomezia | Manufacturing Plant, R&D Lab Centre, Offices
Specialising in both Captive and CMO activities, soft gel drugs and advanced R&D.
Sermoneta | API facility
Specialising in API and nutritional ingredients for food supplements, in both Captive and CMO activities.
KM Rosso | R&D Lab Centre
Innovative laboratory for microbiological analysis related to the world of microbiota and probiotics.
LABIO 4.0 | Tech Centre & Pilot Plant
Launched in 2021, integrated R&D Lab with a pilot plant to develop GMP material ready for clinical setting.
Shreveport | Nutraceutics Manufacturing, R&D
Acquired in 2017, hosts a manufacturing plant and a R&D Lab, both specialising in Nutraceutics.
Tortosa (Tarragona) | Manufacturing Plant
Specialising in Captive productions for the local market.
Morpho is the Contract Development and Manufacturing Organisation (CDMO) arm of Alfasigma, leveraging the Group’s industrial heritage and global manufacturing footprint to deliver end-to-end solutions across pharmaceutical, fine chemical, nutraceutical, and medical food markets.